Status:
COMPLETED
Transcranial Photobiomodulation for the Treatment of Opioid Cravings
Lead Sponsor:
MindLight, LLC
Conditions:
Opioid-use Disorder
Depression, Anxiety
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The investigators wish to test the hypothesis that transcranial photobiomodulation (tPBM) (i.e., 4-minutes of 810nm near-infrared light at 250 mW/cm2 by LED to the forehead at F3 or F4 versus an indis...
Detailed Description
Opioid use disorders (OUD) are an epidemic causing catastrophic consequences to individuals, families, and society despite treatments including psychotherapy, substitution therapy or receptor blockers...
Eligibility Criteria
Inclusion
- patients complain of opioid cravings
- between the ages of 18 and 65.
- meet criteria for a history of opioid dependence by DSM V.
Exclusion
- a past history of a psychotic disorder (including schizophrenia or schizoaffective disorder)
- a history of violent behavior
- a history of a past suicide attempt
- a history of current suicidal ideation
- a history of a neurological condition (e.g. epilepsy, traumatic brain injury, stroke), pregnancy,
- any current acute or chronic medical condition that might confound the study.
- Any patient judged by an investigator to have an impaired decision-making capacity
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2019
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04417738
Start Date
July 1 2019
End Date
November 15 2019
Last Update
May 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MindLight, LLC
Newton Highlands, Massachusetts, United States, 02461